ENIGMA - Trademark Details
Status: 688 - Notice Of Allowance - Issued
Serial Number
90354435
Word Mark
ENIGMA
Status
688 - Notice Of Allowance - Issued
Status Date
2021-11-23
Filing Date
2020-12-02
Mark Drawing
4000 - Standard character mark
Typeset
Published for Opposition Date
2021-09-28
Attorney Name
Law Office Assigned Location Code
M50
Employee Name
CIURPITA, DREW PETER F
Statements
Goods and Services
Pharmaceutical preparations, namely, antivirals; Drug delivery agents in the form of powders that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of tablets that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, bacteria-based diseases or disorders, autoimmune diseases or disorders, kidney diseases or disorders, and diabetes; Pharmaceutical products for the prevention and treatment of cancer; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Analgesic and muscle relaxant pharmaceutical preparations; Antimicrobial preservatives for pharmaceuticals; Pharmaceutical preparations, namely, appetite suppressants; Pharmaceutical preparations, namely, antidepressants; Pharmaceutical preparations for the treatment of eye diseases and conditions; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for treating allergies; Pharmaceutical preparations for treating hypertension; Pharmaceutical preparations for the treatment of infectious diseases; Pharmaceutical preparations, namely, a drug delivery system comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents; Pharmaceutical preparations, namely, injectable contraceptives; Potassium preparations for pharmaceutical purposes; Pharmaceuticals, namely, psychotropics; Pharmaceuticals, namely, lipid lowering agents; Pharmaceuticals, namely, inducers of erections; Pharmaceuticals, namely, antihelmintics; Pharmaceutical antitussive-cold preparations; Ocular pharmaceuticals; Pharmaceutical preparations for the treatment of heart rhythm disorders; Pharmaceutical preparation for the treatment of gout; Pharmaceutical preparations for use in chemotherapy; Pharmaceutical preparations, namely, anticoagulants; Alcohol for pharmaceutical purposes; Prescription and non-prescription medicines, namely, pills, tablets, capsules, caplets, liquid drops, sachets and pharmaceutical preparations for the treatment of cardiovascular disorders; Pharmaceutical preparations, namely, an analgesic for human consumption taken orally; Antibacterial pharmaceuticals; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, for the treatment of bacteria-based diseases, and for the treatment of diabetes, and anti - infective preparations, antiviral preparations, antibiotics, antifungal preparations and vaccines; Pharmaceutical preparations and substances for the treatment of psychiatric diseases and disorders; Cardiovascular pharmaceuticals; Pharmaceutical preparations for treating and preventing tendon and muscle injuries and disorders, sports related injuries, and for knee cartilage regeneration; Pharmaceutical preparations, namely, a topical preparation for the treatment of ocular disorders prescribed by ophthalmologists, eye surgeons, and optometrists; Pharmaceutical products for treating respiratory diseases and asthma; Pharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system; Pharmaceutical preparations for the treatment of inflammatory disorders; Pharmaceutical preparations for use in oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; Pharmaceutical preparations for the treatment of viral infections; Pharmaceutical preparations for treating halitosis; Pharmaceutical preparations for treating hypoglycemia; Pharmaceutical preparations for the treatment of bone fractures; Pharmaceutical preparations for the prevention of osteoporosis; Pharmaceutical preparations for the treatment of hormonal disorders; Pharmaceutical preparations for treating allergic rhinitis; Pharmaceutical preparations for treating asthma; Pharmaceutical products for the treatment of cancer
Classification Information
International Class
005 - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes
005, 006, 018, 044, 046, 051, 052
Class Status Code
6 - Active
Class Status Date
2021-02-08
Primary Code
005
Current Trademark Owners
Party Name
Party Type
20 - Owner at Publication
Legal Entity Type
03 - Corporation
Address
Please log in with your Justia account to see this address.
Trademark Owner History
Correspondences
Name
Justin Brown
Address
Please log in with your Justia account to see this address.
Trademark Events
Event Date | Event Description |
2020-12-05 | NEW APPLICATION ENTERED IN TRAM |
2021-02-08 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
2021-05-19 | ASSIGNED TO EXAMINER |
2021-05-28 | NON-FINAL ACTION WRITTEN |
2021-05-28 | NON-FINAL ACTION E-MAILED |
2021-05-28 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
2021-08-11 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
2021-08-11 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
2021-08-12 | TEAS/EMAIL CORRESPONDENCE ENTERED |
2021-08-25 | EXAMINERS AMENDMENT -WRITTEN |
2021-08-25 | EXAMINERS AMENDMENT E-MAILED |
2021-08-25 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
2021-08-25 | EXAMINER'S AMENDMENT ENTERED |
2021-08-25 | APPROVED FOR PUB - PRINCIPAL REGISTER |
2021-09-08 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
2021-09-28 | PUBLISHED FOR OPPOSITION |
2021-09-28 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
2021-11-23 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |